Maintenance Therapy: Clinical Trials

7 trials of Maintenance Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 3 recruiting, 1 unknown. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Not yet recruiting 3, Recruiting 3, Unknown 1

Follow Maintenance Therapy: new trials by email Literature Review of Maintenance Therapy trials Research Report on Maintenance Therapy

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
Maintenance Therapy, No intervention - Myeloid Disorders, Myelodysplastic Syndromes
Phase 2Not yet recruitingMedical College of Wisconsin4502026-12-012026-10-13
Becotatug Vedotin Plus Pucotenlimab and Capecitabine Followed by Concurrent Chemoradiotherapy-Immunotherapy for Locally Advanced Squamous Cell Carcinoma of the Anal Canal
Induction therapy, Concurrent chemoradiotherapy-immunotherapy, Maintenance therapy - Squamous Cell Carcinoma of the Anal Canal
Phase 2Not yet recruitingWang Xin342026-09-202026-09-08
Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer
maintenance therapy plus lubiprostone, maintenance therapy - Colorectal Cancer Metastatic, Peritoneal (Metastatic) Cancer
Phase 2Not yet recruitingSun Yat-sen University1242026-02-242026-02-12
Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial
Induction Therapy, Maintenance Therapy - Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli,SBLPN
Phase 2RecruitingInstitute of Hematology & Blood Diseases Hospital, China472025-09-042025-12-18
Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy Compared to Maintenance Therapy Alone in Advanced Pancreatic Cancer
Stereotactic Body Radiotherapy (SBRT) with maintenance therapy, Maintenance therapy - Pancreatic Cancer Non-resectable
Phase 2RecruitingShandong Cancer Hospital and Institute242025-08-142026-05-20
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
Surgery, carboplatin/taxane, carboplatin/gemcitabine, cisplatin/gemcitabine, liposome doxorubicin/carboplatin..., Niraparib - Ovarian Cancer Recurrent, Fallopian Tube Cancer
Phase 2RecruitingShanghai Gynecologic Oncology Group1672019-10-182022-03-18
Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma
induction phase1, induction phase2, protocol M - Lymphoma, Lymphoblastic
Phase 2UnknownSun Yat-sen University502015-03-012023-06-18

Conditions studied

Colorectal Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasm, Residual (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Sun Yat-sen University (2)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Medical College of Wisconsin (1)  ·  Shandong Cancer Hospital and Institute (1)  ·  Shanghai Gynecologic Oncology Group (1)  ·  Wang Xin (1)

Countries

China (5)  ·  United States (1)

Top investigators

Hua Wang, MD. (1)  ·  Rongyu Zang, M.D., Ph.D. (1)  ·  Sameem Abedin, MD (1)  ·  Shuhua Yi, Dr (1)  ·  Tingyan Shi, M.D., Ph.D. (1)

Results publications

PMID 24475787, PMID 32319233